Innovation: New business opportunities starts from a new vision of the World. We strongly believe in markets opportunities related to the new global laws and regulations for plant-based medicines.
Research: Behind every investment strategy there is an accurate research. Research is what bring us to find different business opportunities to increase stakeholder’s benefits world’s wealth and create a healthier way to do business.
As our industry continues to rapidly evolve, product diversity, world-class research and supply-chain advancements are becoming increasingly important. Our sharp focus on innovation at the global stage is accomplished through ongoing strategic investment and partnerships with disruptive brands and organizations, and acquisitions.
There are over 100 active compounds contained in Cannabis plants, with cannabinoids and terpenes being the two largest groups. Two cannabinoids are the most significant of these compounds:
It is the terpenes in Cannabis which are responsible for its strong smell.
In the United Kingdom THC and other cannabinoids are deemed controlled substances under the MDA 1971, while CBD is not deemed to be a controlled substance.
The Cannabis market has four distinct categories:
In addition to the Cannabis market, there is also a substantial Hemp industry which has four main product groups; fibres, shivs, pharmaceuticals and seeds.